Ipraalox 20 mg 14 gastro-resistant tablets
IPRAALOX is used for the short-term treatment of symptoms of gastroesophageal reflux disease (eg heartburn, acid regurgitation) in adults. Gastroesophageal reflux is the backflow of stomach acid into the esophagus, which can become inflamed and painful. This can cause symptoms such as a burning sensation in the chest rising to the throat (heartburn) and a sour taste in the mouth (acid regurgitation). Acid reflux and heartburn may disappear after one day of treatment with IPRAALOX. However, this medication is not intended to provide immediate relief. It may be necessary to continue treatment for 2 or 3 consecutive days for the improvement of symptoms. IPRAALOX contains an active substance, pantoprazole, which reduces the amount of acid produced in the stomach by blocking the 'proton pump'. Each gastro-resistant tablet contains 20 mg of pantoprazole (as pantoprazole sodium sesquihydrate). Excipients with known effect: each tablet contains 38.425 mg of maltitol, 0.345 mg of soy lecithin (derived from soybean oil) and a maximum of 1.84 mg of sodium. Core: maltitol (E 965), crospovidone type B, carmellose sodium, anhydrous sodium carbonate, calcium stearate. Coating: polyvinyl alcohol, talc, titanium dioxide (E171), macrogol 3350, soya lecithin, yellow iron oxide (E172), anhydrous sodium carbonate, copolymer of methacrylic acid and ethyl acrylate (1:1 ) containing polysorbate 80 and sodium laury sulfate, triethyl citrate.
